Terry P Gould - Net Worth and Insider Trading
Terry P Gould Net Worth
The estimated net worth of Terry P Gould is at least $31 Million dollars as of 2024-11-10. Terry P Gould is the Director, 10% Owner of Corvus Pharmaceuticals Inc and owns about 2,814,187 shares of Corvus Pharmaceuticals Inc (CRVS) stock worth over $27 Million. Terry P Gould is the Director of Icosavax Inc and owns about 256,783 shares of Icosavax Inc (ICVX) stock worth over $4 Million. Terry P Gould is also the Director, 10% Owner of Aptinyx Inc and owns about 695,326 shares of Aptinyx Inc (APTX) stock worth over $66,751. Details can be seen in Terry P Gould's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Terry P Gould has not made any transactions after 2021-08-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Terry P Gould
Terry P Gould Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Terry P Gould owns 4 companies in total, including Aptinyx Inc (APTX) , Corvus Pharmaceuticals Inc (CRVS) , and OncoMed Pharmaceuticals Inc (OMED) among others .
Click here to see the complete history of Terry P Gould’s form 4 insider trades.
Insider Ownership Summary of Terry P Gould
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APTX | Aptinyx Inc | 2018-06-25 | director & 10 percent owner |
| CRVS | Corvus Pharmaceuticals Inc | 2018-03-12 | director & 10 percent owner |
| OMED | OncoMed Pharmaceuticals Inc | 2016-06-22 | director |
 | | 2021-08-02 | director & 10 percent owner |
Terry P Gould Latest Holdings Summary
Terry P Gould currently owns a total of 3 stocks. Among these stocks, Terry P Gould owns 2,814,187 shares of Corvus Pharmaceuticals Inc (CRVS) as of March 12, 2018, with a value of $27 Million and a weighting of 86.93%. Terry P Gould owns 256,783 shares of Icosavax Inc (ICVX) as of August 2, 2021, with a value of $4 Million and a weighting of 12.85%. Terry P Gould also owns 695,326 shares of Aptinyx Inc (APTX) as of June 25, 2018, with a value of $66,751 and a weighting of 0.22%.
Latest Holdings of Terry P Gould
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals Inc | 2018-03-12 | 2,814,187 | 9.45 | 26,594,067 |
| ICVX | Icosavax Inc | 2021-08-02 | 256,783 | 15.31 | 3,931,348 |
| APTX | Aptinyx Inc | 2018-06-25 | 695,326 | 0.10 | 66,751 |
Holding Weightings of Terry P Gould
Terry P Gould Form 4 Trading Tracker
According to the SEC Form 4 filings, Terry P Gould has made a total of 0 transactions in Corvus Pharmaceuticals Inc (CRVS) over the past 5 years. The most-recent trade in Corvus Pharmaceuticals Inc is the acquisition of 588,235 shares on March 12, 2018, which cost Terry P Gould around $5 Million.
According to the SEC Form 4 filings, Terry P Gould has made a total of 1 transactions in Icosavax Inc (ICVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Icosavax Inc is the acquisition of 133,334 shares on August 2, 2021, which cost Terry P Gould around $2 Million.
According to the SEC Form 4 filings, Terry P Gould has made a total of 0 transactions in Aptinyx Inc (APTX) over the past 5 years. The most-recent trade in Aptinyx Inc is the acquisition of 150,000 shares on June 25, 2018, which cost Terry P Gould around $2 Million.
Insider Trading History of Terry P Gould
- 1
Terry P Gould Trading Performance
GuruFocus tracks the stock performance after each of Terry P Gould's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Terry P Gould is 27.39%. GuruFocus also compares Terry P Gould's trading performance to market benchmark return within the same time period. The performance of stocks bought by Terry P Gould within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Terry P Gould's insider trading performs compared to the benchmark.
Performance of Terry P Gould
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.82 | | | | | |
| Relative Return to S&P 500(%) | 13.72 | | | | | |
Terry P Gould Ownership Network
Ownership Network List of Terry P Gould
Ownership Network Relation of Terry P Gould
Terry P Gould Owned Company Details
What does Aptinyx Inc do?
Who are the key executives at Aptinyx Inc?
Terry P Gould is the director & 10 percent owner of Aptinyx Inc. Other key executives at Aptinyx Inc include director & CEO and President Norbert G Riedel , CFO and CBO Ashish Khanna , and 10 percent owner Bain Capital Life Sciences Investors, Llc .
Aptinyx Inc (APTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aptinyx Inc (APTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptinyx Inc (APTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aptinyx Inc (APTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aptinyx Inc Insider Transactions
Terry P Gould Mailing Address
Above is the net worth, insider trading, and ownership report for Terry P Gould. You might contact Terry P Gould via mailing address: C/o Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
